The latest news about Lumendi
Demonstrating Significant Time and Cost Savings in Colorectal ESD
DiLumen Reduced Total Procedure Time by 36.5%, Leading to an Average Cost Savings of $610.16 Per Patient and Improved En Bloc Resection Rate to 97.2%
EZ¹ successfully completes Customer Evaluation phase.
A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.
Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE
Lumendi Receives 510(k) Clearance for Two New Devices
Lumendi, LLC has received U.S. Food and Drug Administration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies.
Expansion of the Dilumen Platform
DiLumen EZ¹ The DiLumen EZ¹ is a variant of the DiLumen design, specially intended for the removal of complex polyps using the EMR* technique. Thanks to its unique balloon design,… Continue reading Expansion of the Dilumen Platform
Lumendi Files for 510(k) Clearance for Two New Products
A successful Digestive Disease Week (DDW) conference in San Diego
Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.